Difficulty: Medium
Average Score: 85%
Practice
We have a patient with a recently diagnosed adrenal cortical adenoma. Among the pertinent cushinoid signs and symptoms are hypertension and weight gain from fluid retention, and hypernatremia and hypokalemia. Which of the following drugs would be the most rational to prescribe, alone or adjunctively, to specifically antagonize both the renal and the systemic effects of the hormone excess?
Correct answer
D
Rationale
The correct answer is D) Spironolactone. Spironolactone is a potassium-sparing diuretic that acts as an aldosterone receptor antagonist. In the case of adrenal cortical adenoma causing Cushing's syndrome, excess aldosterone is produced, leading to hypertension, fluid retention, hypernatremia, and hypokalemia. Spironolactone helps antagonize the effects of aldosterone by promoting the excretion of sodium and water while retaining potassium, thereby addressing the renal and systemic effects of hormone excess.
Option A) Acetazolamide is a carbonic anhydrase inhibitor that primarily acts in the proximal convoluted tubule of the nephron, promoting bicarbonate excretion. It is not specific for antagonizing aldosterone effects.
Option B) Amiloride is a potassium-sparing diuretic that acts on the distal convoluted tubule and collecting duct. While it helps in potassium retention, it does not target aldosterone receptors directly.
Option C) Metolazone is a thiazide-like diuretic that acts in the distal convoluted tubule. It increases sodium and water excretion but does not specifically counteract the effects of excess aldosterone seen in Cushing's syndrome.
Educationally, understanding the mechanism of action of different diuretics is crucial for nurses and healthcare providers to make informed decisions when managing patients with fluid and electrolyte imbalances. This question highlights the importance of selecting the appropriate diuretic based on the underlying pathophysiology to achieve optimal therapeutic outcomes.
Option A) Acetazolamide is a carbonic anhydrase inhibitor that primarily acts in the proximal convoluted tubule of the nephron, promoting bicarbonate excretion. It is not specific for antagonizing aldosterone effects.
Option B) Amiloride is a potassium-sparing diuretic that acts on the distal convoluted tubule and collecting duct. While it helps in potassium retention, it does not target aldosterone receptors directly.
Option C) Metolazone is a thiazide-like diuretic that acts in the distal convoluted tubule. It increases sodium and water excretion but does not specifically counteract the effects of excess aldosterone seen in Cushing's syndrome.
Educationally, understanding the mechanism of action of different diuretics is crucial for nurses and healthcare providers to make informed decisions when managing patients with fluid and electrolyte imbalances. This question highlights the importance of selecting the appropriate diuretic based on the underlying pathophysiology to achieve optimal therapeutic outcomes.